Recent News

• 10.03.2025 - Candel Therapeutics to Present at the SITC 2025 Annual Meeting
• 10.03.2025 - Candel Therapeutics to Present at the SITC 2025 Annual Meeting
• 09.29.2025 - Candel Therapeutics Presents Phase 3 Clinical Trial of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
• 09.29.2025 - Candel Therapeutics Presents Phase 3 Clinical Trial of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
• 09.17.2025 - Candel Therapeutics to Present Phase 3 Results of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
• 09.17.2025 - Candel Therapeutics to Present Phase 3 Results of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
• 09.05.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.05.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.04.2025 - Cantor Global Healthcare Conference
• 09.04.2025 - Cantor Global Healthcare Conference

Recent Filings

• 08.22.2025 - EFFECT Notice of Effectiveness
• 08.21.2025 - 8-K Current report
• 08.20.2025 - UPLOAD SEC-generated letter
• 08.20.2025 - CORRESP Correspondence